These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 35860327)

  • 1. Towards Better Governance on Biosafety and Biosecurity: China's Advances and Perspectives in Medical Biotechnology Legislation.
    Xue Y; Shang L
    Front Bioeng Biotechnol; 2022; 10():939295. PubMed ID: 35860327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. China's evolving biosafety/biosecurity legislations.
    Cao C
    J Law Biosci; 2021; 8(1):lsab020. PubMed ID: 34221436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are we ready for the revision of the 14-day rule? Implications from Chinese legislations guiding human embryo and embryoid research.
    Xue Y; Shang L
    Front Cell Dev Biol; 2022; 10():1016988. PubMed ID: 36353513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sustainable balance between innovation and risk: How the "right to science" affects China's medical biotechnology regulatory policy.
    Han Y; Fan LL; Xue Y
    Comput Struct Biotechnol J; 2024 Dec; 24():306-313. PubMed ID: 38681134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Brazilian High- and Maximum-Containment Laboratories Biosafety and Biosecurity Regulations to Legal Frameworks in the United States and Other Countries: Gaps and Opportunities.
    Mendonça AO; Zuelke KA; Kahl-Mcdonagh MM; Mafra C
    Appl Biosaf; 2024 Mar; 29(1):45-56. PubMed ID: 38434103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioethics in
    Wang L; Wang F; Zhang W
    J Law Biosci; 2021; 8(1):lsab019. PubMed ID: 34150309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Codification and Prospect of China's Codification of Environmental Law from the Perspective of Global Environmental Governance.
    Xu K; Tian G
    Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosafety and biosecurity: treading China's synbio tightrope.
    Lou Y; Tang X; Liao L; Deng Z; Gao J
    Trends Biotechnol; 2024 Apr; 42(4):389-392. PubMed ID: 37957090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hidden face of academic researches on classified highly pathogenic microorganisms.
    Devaux CA
    Infect Genet Evol; 2015 Jan; 29():26-34. PubMed ID: 25445654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. China's Marriage Law: a model for family responsibilities and relationships.
    Hare-Mustin RT
    Fam Process; 1982 Dec; 21(4):477-81. PubMed ID: 7160464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strengthening regulatory capacity for gene drives in Africa: leveraging NEPAD's experience in establishing regulatory systems for medicines and GM crops in Africa.
    Glover B; Akinbo O; Savadogo M; Timpo S; Lemgo G; Sinebo W; Akile S; Obukosia S; Ouedraogo J; Ndomondo-Sigonda M; Koch M; Makinde D; Ambali A
    BMC Proc; 2018; 12(Suppl 8):11. PubMed ID: 30079102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baby doe redux? The Department of Health and Human Services and the Born-Alive Infants Protection Act of 2002: a cautionary note on normative neonatal practice.
    Sayeed SA
    Pediatrics; 2005 Oct; 116(4):e576-85. PubMed ID: 16199687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Legislative and judicial responses to workplace sexual harassment in mainland China: Progress and drawbacks.
    Wang H
    Front Public Health; 2022; 10():1000488. PubMed ID: 36225785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety risks and ethical governance of biomedical applications of synthetic biology.
    Ou Y; Guo S
    Front Bioeng Biotechnol; 2023; 11():1292029. PubMed ID: 37941726
    [No Abstract]   [Full Text] [Related]  

  • 16. Medical Insurance Information Systems in China: Mixed Methods Study.
    Li Y; Lu C; Liu Y
    JMIR Med Inform; 2020 Sep; 8(9):e18780. PubMed ID: 32673209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Top-Down and Bottom-Up Approaches to Environmental Governance in China: Evidence from the River Chief System (RCS).
    Ouyang J; Zhang K; Wen B; Lu Y
    Int J Environ Res Public Health; 2020 Sep; 17(19):. PubMed ID: 32992495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Malaysia Ready for Human Gene Editing: A Regulatory, Biosafety and Biosecurity Perspective.
    Kalidasan V; Theva Das K
    Front Bioeng Biotechnol; 2021; 9():649203. PubMed ID: 33777918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biosafety and biosecurity.
    Zhou D; Song H; Wang J; Li Z; Xu S; Ji X; Hou X; Xu J
    J Biosaf Biosecur; 2019 Mar; 1(1):15-18. PubMed ID: 32501430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Legislative Reform for the Food Safety System of China: A Regulatory Paradigm Shift and Collaborative Governance.
    Han Y
    Food Drug Law J; 2015; 70(3):453-80, ii-iii. PubMed ID: 26630825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.